The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1-Reference-Cited by-同舟云学术

The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1

Published:2012-10-30 Issue:1 Volume:7 Page:
ISSN:1746-1596
Container-title:Diagnostic Pathology
language:en
Short-container-title:Diagn Pathol

Author:

Radwan Nehal A,Ahmed Naglaa S

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/1746-1596-7-149.pdf

Reference34 articles.

1. Waly Raphael S, Yangde Z, Yuxiang C: Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncol. 2012, 2012: 421673-

2. Anwar WA, Khaled HM, Amra HA, El-Nezami H, Loffredo CA: Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat Res. 2008, 659 (1–2): 176-184.

3. Aleem E, Elshayeb A, Elhabachi N, Mansour AR, Gowily A, Hela A: Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection. Oncol Lett. 2012, 3 (3): 704-712.

4. Lamps LW, Folpe AL: The diagnostic value of hepatocyte paraffin antibody 1 in differentiating hepatocellular neoplasms from nonhepatic tumors: a review. Adv Anat Pathol. 2003, 10 (1): 39-43. 10.1097/00125480-200301000-00004.

5. Fujiwara M, Kwok S, Yano H, Pai RK: Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies. Cancer Cytopathol. 2012, 120 (4): 230-237. 10.1002/cncy.21190.

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The utility of next‐generation sequencing in challenging liver FNA biopsies;Cancer Cytopathology;2024-08-04

2. Tumours and Tumour-Like Lesions;MacSween's Pathology of the Liver;2024

3. Potential involvement of oncostatin M in the immunosuppressive tumor immune microenvironment in hepatocellular carcinoma with vessels encapsulating tumor clusters;Hepatology Research;2023-11-29

4. Ancillary tests for hepatobiliary neoplasms: what we know and what we need to know;Human Pathology;2023-11

5. Arginase-1 is More Specific Than Hepatocyte Paraffin 1 for Differentiating Hepatocellular Carcinomas With Cytoplasmic Clearing from Nonhepatocellular Clear Cell Tumors in Liver Biopsies;Applied Immunohistochemistry & Molecular Morphology;2023-10-20